Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
imiquimod (aldara) (1 trial)
Keratosis (Phase 3)
Keratosis, Actinic (Phase 3)
Trials (1 total)
Trial APIs (1 total)